Syndax Pharmaceuticals, Inc.
SNDX
$19.84
$0.763.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -220.77M | -243.25M | -285.42M | -311.58M | -334.99M |
| Total Depreciation and Amortization | 15.00K | 10.00K | 6.00K | 3.00K | 2.00K |
| Total Amortization of Deferred Charges | 420.00K | 172.00K | 228.00K | 259.00K | 197.00K |
| Total Other Non-Cash Items | 49.09M | 45.85M | 41.53M | 40.81M | 36.49M |
| Change in Net Operating Assets | -49.40M | -80.94M | -79.32M | -40.37M | -4.36M |
| Cash from Operations | -220.64M | -278.16M | -322.98M | -310.88M | -302.67M |
| Capital Expenditure | -227.00K | -187.00K | -187.00K | -131.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.71M | 234.47M | 290.22M | -60.38M | -46.10M |
| Cash from Investing | 175.48M | 234.28M | 290.04M | -60.52M | -46.10M |
| Total Debt Issued | 250.00M | -- | -- | -- | -- |
| Total Debt Repaid | -6.15M | -- | -- | -- | -- |
| Issuance of Common Stock | 29.04M | 20.66M | 13.68M | 11.53M | 8.35M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 343.65M | 343.65M |
| Cash from Financing | 272.88M | 20.66M | 13.68M | 355.18M | 352.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 227.73M | -23.22M | -19.27M | -16.21M | 3.24M |